Cargando…

Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway

The metastasis of esophageal squamous cell carcinoma (ESCC) is a leading cause of death worldwide, however, it has a poor prognosis. Ginsenoside Rh4 is a rare saponin that has been shown to have potential antitumor effectiveness in ESCC. However, the utility of Rh4 in ESCC metastasis and its undisco...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Jun, Duan, Zhiguang, Liu, Yannan, Fu, Rongzhan, Zhu, Chenhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331240/
https://www.ncbi.nlm.nih.gov/pubmed/35893895
http://dx.doi.org/10.3390/nu14153042
_version_ 1784758353318117376
author Chen, Jun
Duan, Zhiguang
Liu, Yannan
Fu, Rongzhan
Zhu, Chenhui
author_facet Chen, Jun
Duan, Zhiguang
Liu, Yannan
Fu, Rongzhan
Zhu, Chenhui
author_sort Chen, Jun
collection PubMed
description The metastasis of esophageal squamous cell carcinoma (ESCC) is a leading cause of death worldwide, however, it has a poor prognosis. Ginsenoside Rh4 is a rare saponin that has been shown to have potential antitumor effectiveness in ESCC. However, the utility of Rh4 in ESCC metastasis and its undiscovered mode of action has not yet been explored. In this study, we found that Rh4 could inhibit ESCC metastasis by regulating the Wnt/β-catenin signaling pathway and the level of c-Myc, which is an important transcription factor in cancer. In in vitro experiments, Rh4 could inhibit the migration and invasion of ESCC cells without affecting cell viability. In in vivo experiments, Rh4 restrained ESCC metastasis to the lymph nodes and lungs via the suppression of epithelial-mesenchymal transition (EMT). The Wnt agonist HLY78 promoted EMT and migration of ESCC cells, whereas treatment of Rh4 can attenuate the promotion effect of HLY78. The siRNA knocking out c-Myc can also significantly reduce the expression of EMT-related marker proteins. This study illustrates a new concept for further research on the mechanism of Rh4 in ESCC.
format Online
Article
Text
id pubmed-9331240
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-93312402022-07-29 Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway Chen, Jun Duan, Zhiguang Liu, Yannan Fu, Rongzhan Zhu, Chenhui Nutrients Article The metastasis of esophageal squamous cell carcinoma (ESCC) is a leading cause of death worldwide, however, it has a poor prognosis. Ginsenoside Rh4 is a rare saponin that has been shown to have potential antitumor effectiveness in ESCC. However, the utility of Rh4 in ESCC metastasis and its undiscovered mode of action has not yet been explored. In this study, we found that Rh4 could inhibit ESCC metastasis by regulating the Wnt/β-catenin signaling pathway and the level of c-Myc, which is an important transcription factor in cancer. In in vitro experiments, Rh4 could inhibit the migration and invasion of ESCC cells without affecting cell viability. In in vivo experiments, Rh4 restrained ESCC metastasis to the lymph nodes and lungs via the suppression of epithelial-mesenchymal transition (EMT). The Wnt agonist HLY78 promoted EMT and migration of ESCC cells, whereas treatment of Rh4 can attenuate the promotion effect of HLY78. The siRNA knocking out c-Myc can also significantly reduce the expression of EMT-related marker proteins. This study illustrates a new concept for further research on the mechanism of Rh4 in ESCC. MDPI 2022-07-25 /pmc/articles/PMC9331240/ /pubmed/35893895 http://dx.doi.org/10.3390/nu14153042 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Chen, Jun
Duan, Zhiguang
Liu, Yannan
Fu, Rongzhan
Zhu, Chenhui
Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway
title Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway
title_full Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway
title_fullStr Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway
title_full_unstemmed Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway
title_short Ginsenoside Rh4 Suppresses Metastasis of Esophageal Cancer and Expression of c-Myc via Targeting the Wnt/β-Catenin Signaling Pathway
title_sort ginsenoside rh4 suppresses metastasis of esophageal cancer and expression of c-myc via targeting the wnt/β-catenin signaling pathway
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9331240/
https://www.ncbi.nlm.nih.gov/pubmed/35893895
http://dx.doi.org/10.3390/nu14153042
work_keys_str_mv AT chenjun ginsenosiderh4suppressesmetastasisofesophagealcancerandexpressionofcmycviatargetingthewntbcateninsignalingpathway
AT duanzhiguang ginsenosiderh4suppressesmetastasisofesophagealcancerandexpressionofcmycviatargetingthewntbcateninsignalingpathway
AT liuyannan ginsenosiderh4suppressesmetastasisofesophagealcancerandexpressionofcmycviatargetingthewntbcateninsignalingpathway
AT furongzhan ginsenosiderh4suppressesmetastasisofesophagealcancerandexpressionofcmycviatargetingthewntbcateninsignalingpathway
AT zhuchenhui ginsenosiderh4suppressesmetastasisofesophagealcancerandexpressionofcmycviatargetingthewntbcateninsignalingpathway